GAL and cancer: Among the most recurring ligands, we found several instances that are either invariably associated to lower survival, e.g., CXCL5, CXCL1, GAL, and RPS19, or have opposite associations depending on the cancer type, e.g., CXCL9 (Figures 4B, and Table S8).